(Total Views: 774)
Posted On: 02/11/2021 7:36:08 AM
Post# of 155622
Scott Kelly will be presenting at the Triple Negative Breast Cancer Drug Development Summit, April 28th.
Scroll down to 4:30pm on the agenda.
https://tnbc-summit.com/program/agenda/
Scroll down to 4:30pm on the agenda.
https://tnbc-summit.com/program/agenda/
Quote:
4:30 pm The Role of Leronlimab to Treat TNBC
Scott Kelly
Chief Medical Officer , Cytodyn
Synopsis
• Mechanisms of action of Leronlimab
• Leronlimab in the tumor microenvironment
(8)
(0)
